Toxicologic pathology is crucial in the identification and characterization of health effects following exposure to xenobiotics, mainly in toxicity experiments in rodents. Regarding regulatory toxicology, histopathology of lymphoid organs and tissues is a cornerstone in the identification of immunotoxic compounds. A 2-tier testing system is usually employed in which the first tier is a general screen for (immuno)toxicity and the second tier consists of specific immune function studies, including host resistance tests or mechanistic studies. The role attributed to histopathology of lymphoid organs in the updated Organisation for Economic Cooperation and Development and Food and Drug Administration guidelines requires improvement and standardization of the histopathology procedures. Optimalization and standardization was started in an international collaborative immunotoxicity study (ICICIS). However, several problems were left unaddressed, mostly because of the few compounds tested in this study. Based on the results of the ICICIS study and the morphologic changes induced by immunotoxic/immunomodulatory compounds observed in other investigations, suggestions are given to further improve the identification and (semi)quantification of histopathologic changes in lymphoid organs and tissues.
INTRODUCTION
The toxicologic pathology discipline plays a crucial role in the process of identifying and defining the health effects of exposure to toxic compounds. The characterization of morphologic alterations of laboratory animals after exposure is an initial step in this process. Examination of the lymphoid organs and tissues has been of utmost importance in identifying immunotoxic and immunomodulatory agents and has increased the database on these compounds (10, 11, 18, 34, 42) . Such an evaluation should include the analysis of various microenvironments in lymphoid tissues and organs with respect to both the stationary and the passenger components (23) . Several laboratories have developed and validated methods to determine the effects of chemicals on the immune system of rats and mice (16, 17, 25, 31, 38) . Most methods employ a 2-tier testing system in which the first tier is a screen for immunotoxicity and the second tier consists of more specific immune function studies, including host resistance tests or mechanistic studies (25, 26, 31, 36, 38, 41) . Organizations such as the Food and Drug Administration (FDA) and the Organisation for Economic Cooperation and Development (OECD) have been and are updating guidelines to enhance immunotoxicity testing (13, 14, 20) . The updated OECD 407 guideline, under which rats and mice are exposed orally for 28 days to a test compound, now includes weight of thymus and spleen and histopathology of these organs in addition to that of draining and distant lymph nodes and Peyer's patches. This update certainly is an improvement over the earlier guideline, although even with this updated version a few immunotoxic compounds would not have been identified as such (37) . Further improvement may come from the incorporation of additional immune function parameters such as the inclusion of an in vivo antigen challenge test with sheep red blood cells (SRBC), which has been recently recommended (30) . Results of a study by Ladicz et al (24) indicate that intravenous injection with SRBC during a 30-and 90-day toxicity study did not alter hematologic and clinical chemistry parameters. With the expected exception of the spleen (slight increase in number and size of germinal centers), administration of SRBC did not significantly alter the weights or morphology of routine protocol organs and tissues. It is a challenge for the toxicologic pathologists to contribute to a more sensitive detection of the immunotoxic potential Following a short description of the physiology of primary and secondary lymphoid organs and tissues, examples are given here of pathologic changes in lymphoid organs and tissues caused by immunotoxic compounds. We also discuss the ICICIS interlaboratory study, which demonstrated that interlaboratory variation in results could be greatly reduced by standardization of the histopathologic procedures and by prior training of the toxicologic pathologists in a structured assessment scheme, such as that developed by the ICICIS Working Group (16) . This approach, together with our experience in specific studies, forms the basis of our attempts to consolidate evaluation of lesions in lymphoid organs and tissues into an approach that may be useful to toxicologic pathologists for identifying immunotoxicants.
HISTOPHYSIOLOGY OF BONE MARROW, THYMUS, MUCOSA-ASSOCIATED LYMPHOID TISSUE, SPLEEN, AND LYMPH NODE Overview of Lymphoid Organs Components of the immune system are present throughout the body (Figure 1 ) organized in so-called lymphoid organs and as integral parts of other organs.
The lymphoid organs and tissues are generally classified as primary/central and secondary/peripheral or as internal and external. Primary or central organs are the bone marrow and thymus, where lymphocyte proliferation and maturation takes place independent of exogenous antigen exposure. Extrathymic maturation of T lymphocytes also occurs in the small intestines, but it is unclear whether and to what extent this maturation process is driven by exogenous antigen (44) . Antigen-dependent development and proliferation takes place in the secondary lymphoid organs, ie, the spleen, lymph nodes, and mucosa-associated lymphoid tissue (MALT), as well as in the bone marrow and the thymic medulla. A second classification is based on the location of the lymphoid organs: internal organs such as thymus and lymph nodes and external tissue along secretory epithelial surfaces, ie, the MALT. The skin does not contain organized lymphoid tissue, but its immune components are interconnected with those of other lymphoid organs, leading to the concept of the skin immune system or skin-associated lymphoid tissue (2) . The different compartments within lymphoid organs and tissues and the cells present and their function are summarized in Table 1 .
Bone Marrow, Thymus, and MALT
The bone marrow fills the intertrabecular spaces of the hollow bones. Located in the extrasinusoidal spaces of Abbreviations: PALS = periarteriolar lymphocyte sheath; NALT = nose-associated lymphoid tissue; BALT = bronchus-associated lymphoid tissue. the bone marrow are blood and tissue leukocytes grouped together with their progenitors at different stages of maturation. The microenvironment is formed by reticular cells (adventitial and fibroblastic reticular cells), adipocytes, endothelial cells, and extracellular matrix. These components together with passenger cells (macrophages, monocytes, and lymphocytes) support the hemopoietic process (43) . The pluripotent stem cells in the bone marrow proliferate and differentiate to progenitors of myeloid, erythroid, and lymphoid cells. Progenitor T cells move to the thymus and intestines for further maturation. As a secondary lymphoid organ, bone marrow cells include a pool of memory lymphocytes and the major plasma cell population contributing to the intravascular pool of immunoglobulins.
The thymus is a bilobed organ, located in the anterior aspect of the thoracic cavity. In weanling and young adult rats, 1 or both lobes extend into the neck (21) . The lobes are attached to each other by connective tissue and are enclosed by a 2-layer fibrous capsule. The inner layer forms the septal network, which divides the lobe into several interconnected lobules. In a first differentiation, lobules are divided into 2 zones, a peripheral lymphocyte-rich cortex and a central less densely populated medulla (Figure 2a ). The medulla forms small buds that reach deep into the cortex and at some places reach the capsule. The key function of the thymus is the production of immunocompetent T lymphocytes by selection and expansion of lymphoid stem cells coming from the bone marrow. For this antigen-independent selection and expansion, contact between the microenvironment and thymocytes is crucial (35) . It is generally accepted that the epithelial microenvironment of the cortex plays a major role in positive selection, whereas negative selection has been ascribed to either the epithelium or the medullary dendritic cells. In so-called epithelium-free areas (EFA), the proliferation rate of the thymocytes is high but the main component of the microenvironment, the epitheli- um, is lacking (5) (Figure 2b ). Hormones produced by the thymic epithelium in cortex and especially medulla have a major function in late intrathymic T-cell maturation. Although thymus weight, volume, and function decrease with age (referred to as age-related thymic involution), the components that constitute the various thymic compartments are still present and functional in healthy older rats, as is shown by reconstitution and regeneration studies (12, 27) .
Lymphocytes associated with the MALT are organized in structures (Figure 3a ) such as Peyer's patches in the small intestines and nose-associated lymphoid tissue (or Waldeyer's ring equivalent) (22) or they are grouped together in less well-organized aggregates (Figure 3b ) such as lymphoid aggregates at the bifurcation of bronchi and bronchioli (bronchus-associated lymphoid tissue), cryptopatches in plump intestinal villi (19) , and the sometimes quite large lymphocyte aggregates in the colon (8) . Afferent lymphatics are lacking in these lymphoid tissues because antigens can enter the tissue through the covering epithelial layer. In addition to the lymphocyte structures, single lymphocytes are observed within the epithelium and lamina propria of the mucosae (Figure 3c ). MALT is involved in the generation of the secretory antibody response and probably in the induction of immunologic tolerance.
Spleen, Lymphatics, Lymph Nodes
The spleen has 2 main compartments, the red pulp and the white pulp ( Figure 4a ). Its main function is to guard the body's vascular compartment by generating immunologic responses against blood-bome pathogens and by filtering the blood. High-volume filtering in the red pulp is facilitated by a direct contact between phagocytic cells and blood. In addition, the red pulp houses a considerable number of natural killer cells (Figure 4b ). The white pulp is located around a central arteriole and comprises the periarteriolar lymphocyte sheath (PALS, T-cell area), adjacent follicles (B-cell area), and marginal zone. The marginal zone microenvironment is unique because of the presence of special macrophages, marginal metallophils, and special types of B lymphocytes that function in Tindependent antibody synthesis (3) .
There is a finely branched lymph vessel system with lymph nodes at regular intervals for the return of interstitial tissue fluid to the blood circulation. The afferent lymphatics penetrate the lymph node capsule and connect with the subcapsular sinus. Based on the lymph flow through the node, basic units can be recognized, consisting of a paracortex with some follicles that is supplied by its own afferent lymph vessel (33) . The lymph leaves the node via the efferent lymphatics at the hilus. The efferent lymphatics drain into other lymph nodes and finally into the thoracic duct, which enters the blood stream.
Lymph nodes are organized structures consisting of a mesenchymal network with T and B lymphocytes and macrophages. Although each lymph node has the same basic architecture, important variations among different regions of the body exist. For example, the superior mesenteric lymph nodes and cervical lymph nodes drain areas that are continuously exposed to antigens from the environment and therefore are generally in a state of ac-tivation ( Figure 5a ). In contrast, lymph nodes such as the popliteal and axillary lymph nodes drain areas that are normally under less or no antigenic pressure; these nodes are small and quiescent, with primary follicles only and a small paracortex (Figure 5b ). The main function of all lymph nodes is the filtering of afferent lymph from lymphatics and subsequent initialization of immune reactions against the filtered foreign antigens.
EXAMPLES OF INDUCED IMMUNOTOXIC CHANGES
The thymus is the first lymphoid organ that shows morphologic alterations after exposure to many immunotoxic agents. A decrease in size (weight) is often the first manifestation of toxicity. Most thymotoxic compounds induce atrophy of the organ as the result of lymphocyte depletion of the cortex: lymphocytes of the thymic cortex appear especially susceptible to the action of toxic compounds, although the cellular targets for toxicity differ (9) . Examples of such toxic compounds are 2,3,7,8tetrachlorodibenzo-p-dioxin, bis(tri-n-butyltin)oxide, cyclophosphamide, and 5-fluorouracil. A few compounds cause expansion of a distinct thymic compartment without a major change in thymus weight, eg, 2-acetyl-4(5)tetrahydroxybutyl-imidazole (THI, Figure 6a -d) and cyclosporin A (CYA) (Figure 7a-e ). CYA is a drug that is widely used as an immunosuppressant in organ transplantation and in the treatment of certain autoimmune diseases. The drug affects the medulla of the thymus. The depletion of interdigitating cells in the medulla is thought to be related to a disturbance in the negative selection process of thymocytes, resulting in the emergence of autoimmune phenomena upon withdrawal of treatment (28) . THI is used as a food color addditive, caramel color III.
In the rat, this compound rapidly reduced the number of B and T lymphocytes in peripheral blood and reduced lymphocyte numbers in spleen and lymph nodes. THIinduced immunosuppression is thought to be due to inhibited migration of mature thymocytes into the periphery (15) . Most of the thymotoxic and immunosuppressive compounds also affect secondary lymphoid organs and tissues, as illustrated in Figure 8a -c by the effect of cyclophosphamide on the spleen. The lack of reports of effects on Peyer's patches may partly depend on the selection of patches for microscopic examination. For example, azathioprine (AZA) decreased the number of mac- (a) Mesenteric node continuously stimulated by antigens from the gastrointestinal tract; they generally have high intra-and internode variability. (b) Popliteal lymph node that is not exposed to antigens and has a quiescent or resting appearance, with primary follicles and a relatively small paracortex and interfollicular area. H&E. From IPCS (17) , with permission. FIGURE 6.-Thymus of control rat (a, c) and rat treated orally with THI (b, d). Histologic appearance in H&E stain (a and b); immunohistochemistry with ED2 that labels macrophages in the cortex but not in the medulla (c and d). THI induces a rapid reduction of B and T lymphocytes in peripheral blood and reduced lymphocyte numbers in spleen and lymph nodes (b). THI also induces enlargement of the thymic medulla at the cost of the cortex (decreased cortex:medulla ratio); thymus weight is a less sensitive parameter. The remaining cortex appears normal in H&E staining, although immunohistochemistry indicates that there are some subtle changes. In contrast to controls (c), macrophages in the thymus cortex of THItreated rat (d) are not stained or only weakly stained with ED2, and septal macrophages are still quite prominent; the remaining cortex is thus not completely normal, as the H&E-stained section suggested. Courtesy of Dr. G. Houben (TNO, Zeist, The Netherlands).
roscopically visible patches, but the patches selected at autopsy and examined microscopically were normal (4). Few compounds have been investigated morphologically/histopathologically that have immunostimulating or immunoadjuvant properties. The limited data available indicate that lymphoid organs may exhibit an increased development of germinal centers in the spleen (Figure  8d ), lymph node enlargement with germinal center development and increased size of paracortex (Figure 9a,   b ), the appearance of macrophage aggregates (Figure 9c ), or increased numbers of macrophages (Figure 9d ) in lymph nodes. Stimulated lymph nodes can also be observed at the draining sites of skin inoculated with compounds with allergenic properties such as dinitrochlorobenzene (DNCB) and trimellitic anhydride. Hexachlorobenzene (HCB) is another example of an agent with immunopotentiating properties, currently used as a reference substance in a validation study of the German BgVV (Federal Institute for Health Protection of Consumers and Veterinary Medicine). HCB is a highly persistent environmental chemical that has been used in the past as a fungicide. Presently, emission in the environment may occur as a result of the use of HCB as a chemical intermediate or as a by-product in chemical processes. In rats, prominent changes following dietary exposure include elevated IgM levels and an increase in the weights of the spleen and lymph nodes. Functional tests revealed an increase in cell-mediated immunity and humoral immunity; the developing immune system of the rat seemed particularly vulnerable to the immunotoxic action of HCB (39) . More recent studies indicate that HCB might cause autoimmune-like effects in the rat. HCB-induced skin lesions are correlated with immune parameters (increased serum IgM, IgE, and single-stranded DNA-specific IgM) and are by far more prominent in Brown Norway rats than in Lewis and Wistar rats (29) . Histopathologically, the spleen shows increased extramedullary hemopoiesis and hyperplasia of B lymphocytes in the marginal zone and follicles. The splenic white pulp effects were T-cell dependent; morphometric analysis indicated that athymic rats did not manifest the hyperplasia of B lymphocytes (40) . Lymph nodes and Peyer's patches ( Figure 10) show an increase in proportions of high endothelial venules (HEV), indicative of activation. HEV-like venules are induced in the lung (Figure 11 a, b), in particular in the Lewis strain rat (29) . Delayed-type hypersensitivity (DTH) reactions are an example of local T-cell-dependent immune responses that are characterized microscopically by an accumulation of mononuclear cells, and these reactions have been investigated most often using the skin. Such reactions may also be elicited in the respiratory tract. Picrylchloride is a compound that can elicit a DTH reaction in the lung following skin sensitization and intranasal challenge. Figures 11 c and 11 d illustrates an allergic reaction in the larynx of a rat sensitized and challenged with DNCB (1). It is unclear whether, without further knowledge, these effects would have been recognized as indications for possible immunoactive properties of the compounds.
THE ICICIS INTERLABORATORY VALIDATION STUDY AND SUGGESTIONS FOR IMPROVEMENTS IN HISTOPATHOLOGIC EVALUATION The ICICIS Study
The most important aim of the ICICIS study was to investigate whether the limited evaluation recommended in the old OECD guideline 407 or the more detailed (enhanced) histopathologic examination of lymphoid organs and tissues of the rat in a conventional 28-day subacute toxicity test should serve as the &dquo;flagging&dquo; system (16) . The approach developed by the pathologists in the ICI-CIS study emphasized 2 aspects. First, the lymphoid organs were examined per compartment; as distinct compartments within a lymphoid organ each features 1 or more specific functions and each houses lymphoid and nonlymphoid cells of different lineages and in different ratios ( Table 1 ). Immunotoxic compounds may have an effect on 1 compartiment and leave others unaffected. Second, the terminology to describe morphologic reflections of functional disturbances had to be quantitative and descriptive rather than interpretative. Because the immune system is highly dynamic, the cellularity of the compartments and the development of germinal centers were considered important aspects in the histopathologic examination of hematoxylin and eosin (H&E)-stained sections. Changes in the number of cells were described as decreased or increased cellularity rather than as atrophy, involution, degeneration, or hyperplasia and proliferation. The 2 model compounds examined were the potent immunosuppressive drugs AZA and CYA (16) . Results of the AZA study showed overall reduced cellularity in the bone marrow, thymus, spleen, lymph nodes, and Peyer's patches. The most consistent indication of the effect of CYA on the immune system was an increase in the thymic cortex: medulla ratio and reduced cellularity of the cortex and medulla. A summary of the histopathology evaluation for CYA is presented in Table 2 . The variability of the results was much less marked in the CYA study than in the AZA study, probably as a result of standardization of protocols, including histopathologic techniques, careful control of procedures, and comprehensive training of investigators.
Suggestions for Further Improvements
The approach developed in the ICICIS study did leave some problems unaddressed. One of the problems in the detection of alterations in cell numbers, germinal center development, sinusoidal macrophages, HEV development, etc, is the discrimination from the &dquo;normal&dquo; morphology ; the range for normal appearance of most lymphoid organs is wide because of the dynamic nature of the immune system. Therefore, it should be established whether the morphologic spectrum of lymphoid organs of all control animals or of only a majority of these animals is to be considered &dquo;normal.&dquo; Preferentially, the criteria used to define &dquo;normal&dquo; should be explained in the Materials and Methods section of the report in the case of treatment-related changes in 1 or more lymphoid compartments. This stipulation also implies that so-called &dquo;blind scoring&dquo; cannot be done right from the beginning FIGURE 7.-Rat thymus 14 days after daily administration of CYA (a, c) and recovery period of 4 weeks (b, d). From IPCS (17), with permission. Histologic appearance in H&E stain (a, b); immunohistochemistry with major histocompatability complex class II antibody that labels epithelium in the cortex in a dendritic pattern and interdigitating cells in the medulla in a more confluent pattern, whereas the epithelium in the medulla is not stained (c, d). (a) The thymus of the CYA-treated rat has a completely altered cortex:medulla ratio, based upon cell density and morphology. Almost the entire medulla has taken on the appearance of cortex (increased cellularity of the medulla or cortification of the medulla); the original cortexmedulla border appears still at its original location, based on the vasculature. There is also an increase in tingible body macrophages in the cortex. (b) The thymus has recovered its normal histologic appearance, with cortex-medulla demarcation. (c) Most of the section is filled with cortex-type epithelium in a dendritic staining pattern. Only a few class II-positive interdigitating cells are present. (d) Recovery with a clear demarcation between cortex and medulla. (e) Thymus of rat treated with high dose of CYA. Aggregates of macrophages in the EFA. (16) .
Abbreviation: PALS = periarteriolar lymphocyte sheath. a Not all labs reported on all compartments, and not all labs examined all 3 dose groups. ' No. of labs in which differences between values for treatment and control groups were significant.
of the examination. Blind scoring can be very helpful at a later stage of the microscopic examination, as performed by the study pathologist or a reviewing pathologist. For a proper evaluation of the immune system, information on dosing regimen, organ weights, blood and bone marrow counts, and flow cytometry analysis, whenever available, also should be known before starting the microscopic examination. Another problem refers to the diagnostic term &dquo;altered cellularity,&dquo; which may be expressed morphologically as altered size of the compartment or altered cell density. In addition, it may apply to an increase in cells that form part of the microenvironment of the organ with a concomitant decrease in lymphocytes. For example, an increase in tingible body macrophages is observed in the thymus cortex in corticosteroid-related thymus involution. Therefore, we propose to restrict the use of the the term &dquo;altered cellularity&dquo; to changes in numbers of passenger cells that are normal constituents of a given compartment. Generally, that means lymphocytes, blasts cells, and plasma cells only. When the number of these cells is affected, the size of the compartment may change rather than cell density because the stroma of most compartments is rather flexible. The changes in size should be recorded as such, leaving the term &dquo;altered cellularity&dquo; for changes in cell density. In addition, the stroma, stationary cells, and vasculature should be carefully examined because these cells interact closely with the passenger lymphocytes and macrophages. Besides (semiquantitative) changes that are expressions of changes in the dynamics of lymphoid organs, typical findings such as rosette formation in lymph node sinuses and granulomata may indicate a toxic effect on the immune system. In the case of erythrocyte rosette formation, macrophage phagocytic capacity may have been affected. Table 3 presents an overview of the diagnostic terms that we propose for the histopathologic evaluation of lymphoid organs and tissues. This overview is certainly not complete. Rather, it illustrates a semiquantitative approach to examining changes in the various compartments of lymphoid organs. Particular components of the immune system may be decreased in number or size or may be increased, but these changes do not necessarily reflect an overall (functional) effect on the immune system.
Immune System-Related Effects in Nonlymphoid Organs
The classical lymphoid organs are not the only sites where cells of the immune system are housed and where immune events take place. For instance, subsets of macrophages reside in almost every organ, and there are even Abbreviation: MALT = mucosa-associated lymphoid tissue. more macrophages in lungs and liver than in thymus and spleen. Moreover, immunologic processes such as autoimmunity and hypersensitivity/allergy lead to tissue damage, protein (immune) complex deposits, and/or inflammatory cell infiltrates predominantly in nonlymphoid organs. Well-known nonlymphoid target sites are vasculature, kidneys, synovial membranes, thyroid, skin, liver, and lungs (32) . Histopathologic changes in nonlymphoid organs per se can be indicative of immunologic reactions induced by a compound, eg, contact dermatitis. The morphology of lymph nodes that drain the sites where allergenic compounds or compounds with adjuvant properties have been applied (7) and the morphology of lymphoid organs in animals exposed to immunostimulating compounds suggest that, at least at given times, increased sizes of compartments, increased germinal center development, and HEV development may be indicative features.
DISCUSSION
The histopathology of organs and tissues still represents one of the cornerstones in the assessment of immunotoxic effects in animals, and therefore a careful detailed pathologic evaluation is needed. The approach suggested here is aimed at improving the toxicologic pathology of the immune system. The approach focuses on a semiquantitative description of compartments (or microenvironments) in lymphoid tissue with respect to both the stationary and passenger leukocyte component and the stroma (Table 3 ). This careful description can only be acheived when the quality of the histotechnical procedures, including orientation of the tissue in paraffin (23) , is good. In line with the suggestions for the diagnostic approach proposed here, the identification of immunotoxic agents by histopathology is further improved by the addition of phenotyping of cells or cell products such as cytokines to regulatory toxicity guidelines such as the OECD 407, a quantitative evaluation of lymphoid tissues (30) , and development of a uniform grading system. Regarding phenotyping, we must consider whether further development of immunohistochemical methods for use with formalin-fixed, paraffin-embedded sections, in particular for cell membrane markers, is needed. The general availability and validation of methods for phenotyping and quantitative evaluation is essential for inclusion in guidelines for toxicity testing. These additional methods may be used if the initial examination of H&E-stained tissues (in addition to organ weight and clinical pathology parameters) gives an indication of a possible immunomodulatory effect of the test material, as one of the more sensitive targets of toxicity. These additional tests could be used in such cases to help establish a clear no-effect level and give further clues to a possible mechanism of action by identifying cell populations affected. This approach may be useful in the design of subsequent investigations such as tier II. The studies on the thymus of CYAand THI-exposed animals discussed here emphasize the importance of immunohistochemistry in immunotoxicity evaluation. Semiquantitation of effects can be achieved adequately by an experienced pathologist using blind scoring, especially when the effects include a disturbance of the normal architecture. When the architecture is not disturbed or when the effects are too subtle, quantitative methods such as morphometric analysis of the tissue sections or flow cytometric analysis of cell suspensions may be used. The compartmentalization that exists within the immune system, ie, the specific T-lymphocyte and B-lymphocyte areas as they exist in the thymus, spleen, lymph nodes, and MALT, are parameters that are well suited to morphometric investigation. Although these straightforward immunohistochemical techniques and quantitative methods are still not being used in regulatory immunotoxicity testing, newer techniques such as molecular pathology and video microscopy are already available and need to be evaluated for their use in immunotoxicology (6, 23) . The techniques aside, it is the task of the toxicologic pathologist to place the adverse effects on the immune system within the general pathologic evaluation of the affected body. Therefore, the pathologic evaluation also entails the interpretation of changes with regard to the dynamic and complex nature of lymphoid organs. The acknowledgement of immune status assessment in functional terms is required, and thus the close cooperation with other disciplines concerned with immune function is also necessary.
